BofA Securities Downgrades Evotec (EVO) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts EVO Hot Sheet
Price: $1.43 +5.93%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 92
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 92
Join SI Premium – FREE
BofA Securities analyst Derik de Bruin downgraded Evotec (NASDAQ: EVO) from Buy to Neutral with a price target of $13.00.
For an analyst ratings summary and ratings history on Evotec click here. For more ratings news on Evotec click here.
Shares of Evotec closed at $11.85 yesterday.
You May Also Be Interested In
- Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board
- JPMorgan Downgrades Sotera Health (SHC) to Underweight
- HSBC Downgrades Hyosung Heavy Industries Corp (298040:KS) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
